Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Hepatocellular Carcinoma”

669 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 669 results

Testing effectiveness (Phase 2)Looking for participantsNCT05652920
What this trial is testing

Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC

Who this might be right for
Hepatocellular Carcinoma
OriCell Therapeutics Co., Ltd. 105
Testing effectiveness (Phase 2)Study completedNCT00519688
What this trial is testing

UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 44
Testing effectiveness (Phase 2)Looking for participantsNCT06923761
What this trial is testing

EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)

Who this might be right for
Advanced Solid Malignancy
Grey Wolf Therapeutics 300
Testing effectiveness (Phase 2)Looking for participantsNCT06819566
What this trial is testing

Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC

Who this might be right for
Hepatocellular CarcinomaEsophageal VarixBleeding Esophageal Varices
Asan Medical Center 44
Testing effectiveness (Phase 2)Study completedNCT01900002
What this trial is testing

Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaRecurrent Adult Hepatocellular Carcinoma+8 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT03539822
What this trial is testing

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Who this might be right for
Gastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more
Anwaar Saeed 117
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06592612
What this trial is testing

Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

Who this might be right for
Hepatocellular CarcinomaOligoprogression
Sun Yat-sen University 70
Testing effectiveness (Phase 2)Study completedNCT03203005
What this trial is testing

IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
National Cancer Institute, Naples 22
Testing effectiveness (Phase 2)UnknownNCT05603039
What this trial is testing

A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Liver Cancer
Qilu Pharmaceutical Co., Ltd. 80
Testing effectiveness (Phase 2)UnknownNCT00057395
What this trial is testing

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Who this might be right for
Esophageal NeoplasmsHepatocellular CarcinomaColorectal Neoplasms+3 more
Aronex Pharmaceuticals 40
Testing effectiveness (Phase 2)UnknownNCT01533324
What this trial is testing

S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
CarcinomaLiver DiseasesHepatocellular Carcinoma
Second Military Medical University 32
Testing effectiveness (Phase 2)Looking for participantsNCT06015022
What this trial is testing

EGCG for Hepatocellular Carcinoma Chemoprevention

Who this might be right for
Cirrhosis, Liver
University of Texas Southwestern Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06558227
What this trial is testing

Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 90
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Not applicableStudy completedNCT00243841
What this trial is testing

Dose Escalation Study for Primary Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Indiana University 77
Testing effectiveness (Phase 2)Study completedNCT02279719
What this trial is testing

BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sumitomo Pharma America, Inc. 97
Testing effectiveness (Phase 2)Ended earlyNCT00582400
What this trial is testing

A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver

Who this might be right for
Carcinoma, Hepatocellular
The University of Texas Medical Branch, Galveston 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT01840592
What this trial is testing

Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib

Who this might be right for
Hepatocellular Carcinoma
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018947
What this trial is testing

Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC

Who this might be right for
Resectable Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 90
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Load More Results